Economic challenges and possible policy actions to advance stratified medicine

Personalized Medicine
Mark R Trusheim, Ernst R Berndt

Abstract

In this article, we present a simple economic model to illustrate the economic challenges facing an oncology stratified medicine developer when scientific discoveries lead to ever smaller, targeted patient populations.We provide preliminary empirical evidence suggesting that at least some developers and their investors are retreating. We then examine the armamentarium of policy actions beyond higher reimbursement that may be employed to enhance the economic incentives for developing stratified medicines. In the absence of significant pricing and total oncology outlay flexibility by payers, our analysis suggests that private sector investment in small oncology segments, and in stratified medicine generally, may not prove economically sustainable, thus endangering the translation of scientific advances into bedside medicines. Beyond increasing reimbursement, decreasing development cycle time and costs, or both, would most directly improve the economic incentives facing developers. By contrast, extending exclusivity periods, or initiating advance market commitments and awarding prizes would likely have less impact and involve greater implementation challenges.

References

Mar 5, 1999·Breast Cancer Research and Treatment·M D PegramD J Slamon
Feb 28, 2003·Journal of Health Economics·Joseph A DiMasiHenry G Grabowski
Sep 3, 2003·Nature Reviews. Drug Discovery·Janice M Reichert
May 12, 2005·Health Affairs·Ernst R Berndt, John A Hurvitz
Nov 30, 2005·The Pharmacogenomics Journal·A WoelderinkE Rodriguez-Cerezo
Mar 9, 2006·Health Affairs·David B RidleyJeffrey L Moe
Mar 9, 2006·Health Affairs·Christopher P Adams, Van V Brantner
Jan 11, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph A DiMasi, Henry G Grabowski
Jan 26, 2007·Journal of Managed Care Pharmacy : JMCP·Debbie Stern, Debi Reissman
Jan 30, 2007·Clinical Pharmacology and Therapeutics·J Woodcock
Mar 24, 2007·Nature Reviews. Drug Discovery·Mark R TrusheimFrank L Douglas
Nov 15, 2008·Nature Reviews. Drug Discovery·Ian Walker, Herbie Newell
Jul 1, 2009·Journal of the National Cancer Institute·Tito Fojo, Christine Grady
Feb 2, 2011·Nature Reviews. Drug Discovery·Mark McClellanDavid Kessler
Mar 25, 2011·The New England Journal of Medicine·Bruce A Chabner
Nov 1, 2011·Nature Reviews. Drug Discovery·Mark R TrusheimMichael C Palmer
Dec 2, 2011·Nature Reviews. Drug Discovery·Alex Chiang, Ryan P Million
Feb 18, 2012·Clinical Pharmacology and Therapeutics·H-G EichlerG Hirsch

❮ Previous
Next ❯

Citations

Aug 15, 2014·PharmacoEconomics·Alan HaycoxSarah Richards
Oct 21, 2016·Clinical Pharmacology and Therapeutics·M R TrusheimL J Esserman
Sep 5, 2017·Journal of Personalized Medicine·Louis P Garrison, Adrian Towse
Mar 3, 2015·Annals of the New York Academy of Sciences·Naomi Aronson
Sep 1, 2013·Forum for Health Economics & Policy·Gregory Bloss, John G Haaga
Nov 18, 2020·International Journal of Health Economics and Management·Stéphane AlcenatFlorence Naegelen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Deutsche medizinische Wochenschrift
Deutsche medizinische Wochenschrift
Nature Reviews. Drug Discovery
Mark R TrusheimMichael C Palmer
Advances in Experimental Medicine and Biology
Christopher McCabeJeff Round
© 2022 Meta ULC. All rights reserved